A potent complement factor C3–specific nanobody inhibiting multiple functions in the alternative pathway of human and murine complement-Reference-Cited by-同舟云学术

A potent complement factor C3–specific nanobody inhibiting multiple functions in the alternative pathway of human and murine complement

Published:2018-04 Issue:17 Volume:293 Page:6269-6281
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Jensen Rasmus K.,Pihl Rasmus,Gadeberg Trine A.F.,Jensen Jan K.,Andersen Kasper R.,Thiel Steffen,Laursen Nick S.,Andersen Gregers R.

Funder

Lundbeckfonden (Lundbeck Foundation)

Novo Nordisk

Natur og Univers, Det Frie Forskningsråd (FNU, DFF)

Det Frie Forskningsråd (DFF)

Sundhed og Sygdom, Det Frie Forskningsråd (FSS, DFF)

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference63 articles.

1. Complement system part II: role in immunity;Merle;Front. Immunol,2015

2. The complement system: an unexpected role in synaptic pruning during development and disease;stephan;Annu. Rev. Neurosci,2012

3. Complement activation, regulation, and molecular basis for complement-related diseases;Bajic;EMBO J,2015

4. C3 convertase of human complement: enhanced formation and stability of the enzyme generated with nickel instead of magnesium;Fishelson;J. Immunol,1982

5. The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3 (H 2 O) Bb);Bexborn;Mol. Immunol,2008

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reconstitution of the alternative pathway of the complement system enables rapid delineation of the mechanism of action of novel inhibitors;Journal of Biological Chemistry;2024-07

2. Cryo-EM analysis of complement C3 reveals a reversible major opening of the macroglobulin ring;2024-04-15

3. Modular design of bi- and multi-specific knob domain fusions;Frontiers in Immunology;2024-03-27

4. Filtration and tubular handling of EWE‐hC3Nb1, a complement inhibitor nanobody, in wild type mice and a mouse model of proteinuric kidney disease;FEBS Open Bio;2024-01-04

5. Characterization of the bispecific VHH antibody gefurulimab (ALXN1720) targeting complement component 5, and designed for low volume subcutaneous administration;Molecular Immunology;2024-01